IMABP2026
Paris, France October 26-28, 2026
Early Bird Registration February 28, 2026
About Conference
Inscitech Meet On Addiction Medicine, Behavioral Health and Psychiatry
The InSciTech Meet on Addiction Medicine, Behavioural
Health and Psychiatry (IMABP2026) is a premier international conference
focused on showcasing cutting-edge research, clinical breakthroughs, and
innovative practices across addiction medicine, behavioural health, and
psychiatric care. The summit will take place from October 26–28, 2026,
in the iconic city of Paris, France.
IMABP2026 will bring together a global community of leading clinicians,
researchers, mental health professionals, policymakers, and industry experts to
exchange knowledge, foster collaboration, and advance evidence-based strategies
for prevention, treatment, and long-term recovery in mental and behavioural
health.
Organized by InSciTech Summits, this three-day event offers a
multidisciplinary platform for the exchange of pioneering ideas, discussion of
real-world applications, and development of meaningful collaborations between
academia and industry. The scientific program will feature plenary and
keynote lectures, technical sessions, interactive panel discussions, and
extensive networking opportunities, all designed to inspire innovation and
support technological advancement in mental health care.
Market Analysis – IMABP2026
The global market for addiction medicine, behavioural health,
and psychiatry is experiencing rapid growth, driven by the rising prevalence of
mental health and substance use disorders, increased public awareness, expanded
insurance coverage, and the accelerated adoption of telehealth and digital care
solutions.
Important Dates
Conference Updates
- Conference Dates October 26-28, 2026
- Early Bird Registration February 28, 2026
- Abstract Submission Deadline October 20, 2026
- Conference Venue Paris, France
Collaborations and Event Updates
Scientific Sessions
- Preventive, therapeutic, and recovery-oriented approaches in modern psychiatry and addiction treatment.
- Psychedelic-assisted therapy and novel psychopharmacology
- Precision and personalized psychiatry approaches
- Opioid, alcohol, and nicotine use disorder innovations
- Community-based, stigma-reduction, and public mental health strategies
- Opioid harm reduction, overdose prevention, and MAT updates
- Gender-specific and perinatal mental health in addiction care
- Cultural competence and equity in behavioral health services
- Peer support, recovery coaching, and community-based models
- Lifestyle psychiatry: nutrition, exercise, and mind–body interventions
- Clinical innovations in managing co-occurring substance use and mental health disorders
- Advances in addiction neuroscience and brain-based biomarkers
- Trauma-informed care for substance use and mental health disorders
- Adolescent and young adult addiction and behavioural health
- Neuromodulation therapies (TMS, DBS) in psychiatry and addiction
- Behavioural addictions: gaming, gambling, and digital dependency
- Workplace mental health, burnout, and substance use prevention
- Sleep disorders and their role in psychiatric and substance use conditions
- Suicide prevention and crisis intervention strategies
- Legal, ethical, and policy issues in addiction psychiatry
